Meta tags:
description= For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company. Learn more about how we can help.;
keywords= biopharmaceutical services;
Headings (most frequently used words):
the, and, we, of, patients, trials, disease, better, austin, rare, he, they, to, us, when, was, clinical, can, advisory, design, precision, care, with, lives, you, change, patient, member, on, needs, meet, helping, our, council, focus, than, because, insights, quick, websites, regional, resources, smith, rachel, about, sites, participate, report, latest, expertise, inspire, therapeutic, solutions, like, more, for, difference, make, so, ever, faster, deliver, one, who, nonprofit, proudly, broken, concussions, falls, multiple, after, organizations, research, largest, world, among, is, discovered, parexel, wrong, something, realized, parents, his, old, years, are, arm, had, founder, through, co, student, college, today, life, live, slow, treatment, found, however, year, duchenne, each, globally, children, 000, 20, in, diagnosed, condition, dystrophy, muscular, links,
Text of the page (most frequently used words):
and (65), the (40), #patient (26), clinical (24), #development (21), our (21), for (21), #strategy (18), #rare (18), #trials (14), #medical (12), #patients (12), #more (11), expertise (11), disease (11), with (10), solutions (10), trial (10), #global (10), close (10), regulatory (9), drug (9), access (9), diseases (9), insights (9), your (9), learn (8), world (8), therapeutic (8), cell (7), menu (7), management (7), you (7), what (7), #sites (7), excellence (7), gene (7), vice (7), market (7), about (6), privacy (6), annual (6), compliance (6), parexel (6), this (6), research (5), better (5), phase (5), can (5), data (5), treatment (5), therapy (5), delivery (5), optimization (5), see (5), experts (5), meeting (5), meet (5), site (5), team (5), participate (5), including (4), austin (4), provided (4), portfolio (4), are (4), include (4), center (4), evidence (4), medicines (4), rachel (4), real (4), material (4), those (4), advocate (4), only (4), therapies (4), not (4), advice (4), content (4), services (4), get (4), new (4), help (4), deliver (4), communications (4), make (4), care (4), 2024 (4), any (4), their (4), from (3), participating (3), through (3), oncology (3), academy (3), president (3), use (3), under (3), international (3), helps (3), medicine (3), change (3), lives (3), find (3), lifecycle (3), tax (3), that (3), policy (3), asset (3), valuation (3), reach (3), terms (3), however (3), may (3), benefits (3), engagement (3), life (3), early (3), design (3), integrated (3), step (3), contact (3), event (3), every (3), operational (3), summit (3), strategies (3), senior (3), how (3), cross (3), presiden (3), planning (3), years (3), perspectives (3), like (3), careers (3), newsroom (3), perspective (2), neuroscience (2), inflammation (2), immunology (2), included (2), fsp (2), experience (2), collaborate (2), guidance (2), way (2), models (2), leading (2), executive (2), right (2), one (2), novel (2), director (2), achieving (2), today (2), smith (2), fda (2), tech (2), ensuring (2), supplier (2), products (2), indication (2), john (2), need (2), functional (2), volunteers (2), esg (2), needs (2), she (2), study (2), accelerate (2), chapter (2), specialists (2), supports (2), america (2), multiple (2), pay (2), leads (2), gender (2), guided (2), effectively (2), was (2), michael (2), diversity (2), projects (2), graphics (2), biotech (2), expressed (2), largest (2), submissions (2), who (2), disclaimer (2), substantiation (2), they (2), value (2), faster (2), opinions (2), areas (2), approval (2), should (2), considered (2), solicitation (2), promotion (2), advertisement (2), drugs (2), investigational (2), offers (2), potential (2), outsourcing (2), supply (2), cutting (2), innovation (2), all (2), end (2), modern (2), slavery (2), statement (2), act (2), congress (2), final (2), logistics (2), vaccine (2), cro (2), accelerating (2), leveraging (2), than (2), 000 (2), enrollment (2), inclusion (2), protocol (2), biopharmaceutical (2), such (2), represent (2), edge (2), please (2), decisions (2), when (2), images (2), text (2), informational (2), purposes (2), does (2), constitute (2), diagnosis (2), treatments (2), factors (2), consult (2), healthcare (2), professional (2), has (2), consent (2), distribution (2), interested (2), want (2), latest (2), informed (2), changing (2), side (2), time (2), risks (2), contributing (2), effects (2), unpredictable (2), expert (2), while (2), outcomes (2), commitment (2), careful (2), assessment (2), these (2), asgct, greg, rush, peyton, bell, howell, dermatology, aan, acrp, french, susan, jamie, macdonald, salka, 17th, rbqm, cros, orphan, groetelaars, drives, speeding, performance, ascpt, jonathan, iscr, bill, requirements, dpf, framework, complexity, ethics, managing, adaptive, partners, maps, chase, crowley, eric, liu, case, sheri, mccoy, maykin, establishing, edi, bruun, conference, shough, americas, fso, engaging, advantage, customized, driven, technology, risk, pharmacovigilance, safety, digital, gain, iib, passion, designs, innovative, combining, across, utilize, general, vaccines, infectious, solution, biomarker, ahead, review, throughout, explore, claims, profile, assets, into, building, prioritization, based, genomic, model, iia, studies, concept, proof, kol, network, alliance, pediatrics, industry, believe, baltimore, process, joining, thinking, healthy, groups, advocacy, hear, stories, angeles, frequently, los, london, berlin, discuss, opportunity, welcome, would, offer, heart, answers, asked, forefront, revision, stay, advancing, discussions, overview, gap, bridging, binary, beyond, navigator, q5a, questions, ich, exploring, draft, cgt, assurance, potency, product, car, report, ispor, 2023, airis, execution, customize, genetic, field, designations, breakthrough, smoothly, running, everything, keep, relevant, age, deeper, results, approach, first, tactics, capabilities, visit, openings, career, someone, endpoints, genotype, ready, ups, focusing, them, closely, work, why, develop, matter, ensure, experiences, diverse, start, phenotype, allows, around, collaboration, north, south, europe, apac, africa, east, middle, speak, touch, quality, 919, conditions, websites, regional, japan, china, links, quick, 3170, 544, 27713, durham, parkway, meridian, 2520, service, reserved, rights, corporation, invoicing, communication, ever, mind, difference, inspire, because, focus, organizations, among, proudly, range, full, leaders, anywhere, preferences, anyone, option, partnership, works, professionals, breadth, providing, dedicated, resources, improving, steve, ats, weakens, cure, there, lifespan, shortens, greatly, walk, until, muscles, dmd, his, year, each, globally, children, diagnosed, condition, dystrophy, muscular, duchenne, old, parents, discovered, differences, aacr, convention, bio, dia, society, asco, ctr, transition, countdown, scrs, similarities, realized, sclerosis, alzheimer, search, home, scroll, click, story, wrong, something, had, arm, winitsky, angela, indications, focused, hurt, stacy, officer, chief, chris, gotbetter, regulations, wyatt, roessner, martin, presi, corporate, kiely, peter, round, rosamund, pati, satisfy, safely, broken, nonprofit, concussions, falls, after, live, slow, found, helping, council, advisory, member, founder, quickly, student, college, precision, communities, choice, become, timelines, startup, expedite, main,
Text of the page (random words):
cro biopharmaceutical services parexel solutions therapeutic expertise insights participate sites about newsroom academy careers 中国 日本 contact us main menu newsroom academy careers 中国 日本 contact us solutions therapeutic expertise insights participate sites about close menu solutions explore end to end solutions throughout development from portfolio optimization and regulatory strategy to phase i iv clinical trials market access planning and more see solutions what we do portfolio management and asset valuation early development and innovation integrated clinical development approval and access value substantiation lifecycle management how we do it operational excellence biotech delivery models portfolio management and asset valuation building patient insights into assets profile and claims portfolio optimization asset valuation and indication prioritization early evidence review model based drug development integrated development strategy and planning early development and innovation phase i clinical trials proof of concept studies phase ib iia patient engagement strategy and enrollment solutions patient inclusion site alliance network and kol engagement protocol optimization regulatory strategy market access strategy and delivery biomarker and genomic medicine strategy clinical trial supply logistics medical communications integrated clinical development phase iib iv clinical trials real world evidence patient engagement strategy and enrollment solutions patient inclusion protocol driven customized site solution strategy regulatory strategy submissions compliance and outsourcing market access strategy and delivery clinical development technology optimization clinical trial supply logistics medical communications approval and access real world evidence global regulatory submissions and outsourcing compliance and risk management market access strategy and delivery medical communications value substantiation lifecycle management real world evidence market access strategy and planning regulatory compliance drug safety and pharmacovigilance lifecycle optimization medical communications operational excellence leveraging ai and digital in clinical development biotech clinical trial solutions delivery models from fsp to fso gain an advantage through fsp close menu therapeutic expertise utilize our expertise across therapeutic areas combining innovative trial designs leading clinical and regulatory expertise global reach and a passion for changing patient lives see expertise therapeutic expertise neuroscience general medicine infectious disease vaccines inflammation immunology oncology cross therapeutic expertise cell gene therapies pediatrics rare diseases close menu insights our experts help you stay at the forefront of the industry and ahead of change see insights new medicines novel insights advancing rare disease drug development accelerating development of cell and gene therapies achieving patient guided drug development discussions on diversity overview chapter 1 bridging the gap chapter 2 beyond the binary the regulatory navigator exploring ich q5a revision 2 potency assurance for cgt products fda s new draft guidance the fda s final guidance car t product development latest report new medicines novel insights achieving patient guided drug development learn more close menu participate thinking about joining a clinical trial learn the drug development process what it s like to participate how to find a trial and answers to frequently asked questions learn more interested in participating healthy volunteers patient volunteers patient advocacy groups hear from real patients patient stories trial sites baltimore los angeles london berlin close menu sites want to collaborate with us to offer clinical trials at your site we would welcome the opportunity to discuss learn more close menu about we are one of the largest cros in the world speeding life changing medicine to market by engaging patients with heart learn about who we are what we do and what we believe about parexel management team global reach our de i strategy our esg strategy compliance tax privacy meet us at an event management team jamie macdonald peyton howell greg rush john bell michael crowley jonathan shough sheri mccoy eric liu bill chase maykin ho michael bruun john groetelaars susan salka global reach our de i strategy our esg strategy compliance tax privacy compliance ethics tax strategy privacy policy supplier data privacy requirements terms of use french gender pay data uk gender pay data uk modern slavery act statement eu u s data privacy framework eu u s dpf supplier diversity policy meet us at an event world vaccine congress patients as partners u s maps americas ascpt 2024 annual meeting acrp 2024 managing complexity in cell and gene trials establishing an rbqm strategy that drives better performance edi in clinical research the case for adaptive strategies at every step 17th iscr annual conference 2024 include site solutions summit aan annual meeting asgct annual meeting dermatology drug development summit eu world orphan drug congress us ispor us airis ats 2024 aacr annual meeting bio international convention dia global annual meeting international society for cell gene therapy asco final countdown how to transition your trials under eu ctr scrs oncology site solutions summit accelerating vaccine development through operational excellence alzheimer s disease vs multiple sclerosis drug development similarities differences new perspectives close search what can we help you find today home click or scroll the perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation promotion or advertisement for any services of parexel or any drugs or therapies including those under development participating in clinical trials for investigational medicines offers patients potential benefits such as access to cutting edge treatments and expert medical care while contributing to medical research however risks may include side effects unpredictable outcomes and time commitment careful assessment of these factors helps patients make informed decisions the content of this material including graphics images and text is provided for informational purposes only and does not constitute medical advice diagnosis or treatment please consult your healthcare professional for medical advice the patient advocate has provided their consent for the use and distribution of this content close patient story rare diseases oncology inflammation immunology cell gene therapy neuroscience when austin was 3 years old his parents realized something was wrong disclaimer dmd weakens the muscles until the patient can t walk and greatly shortens their lifespan there s no cure after multiple falls concussions and a broken arm they discovered he had duchenne muscular dystrophy a condition diagnosed in 20 000 children globally each year through clinical trials however austin found treatment to slow the disease and live a better life today he s a college student co founder of the nonprofit one rare and a member of our patient advisory council helping us better meet the needs of rare disease patients lives can change when you design rare disease trials with care and precision become a study of choice in patient communities expedite startup and accelerate timelines satisfy global regulations to get your treatment to market safely and quickly find the right experts focused on the right indications what we do we do our experts our rare disease specialists collaborate to help get your treatment to patients like austin faster more experts stacy hurt m h a m b a chief patient officer chris learn ph d p m p senior vice presiden angela qu m d ph d senior vice presiden wyatt gotbetter senior vice presiden martin roessner corporate vice presi peter kiely m d vice president tech rosamund round vice president pati steve winitsky vice president tech rachel smith executive director rare disease center of excellence with 10 years of experience in rare diseases and cell and gene therapy trials rachel leads our global cross functional center of excellence for rare diseases she supports strategies to deliver your projects effectively ensuring the patient perspective is included every step of the way close our experts rachel smith executive director rare disease center of excellence with 10 years of experience in rare diseases and cell and gene therapy trials rachel leads our global cross functional center of excellence for rare diseases she supports strategies to deliver your projects effectively ensuring the patient perspective is included every step of the way we need to develop products that meet the needs of the patient that s why we work so closely with them focusing on improving their quality of life our diverse rare disease experiences ensure you get the expertise you need no matter the indication our collaboration with rare disease clinical trial sites around the world allows us to accelerate study start ups north america south america europe apac middle east africa our field leading genetic specialists customize your endpoints by age genotype and phenotype for better data our global regulatory team helps keep everything running smoothly with expertise in breakthrough therapy designations and more and our patient first approach results in deeper more relevant insights for trial design and execution tactics benefits may include what can we do to help you change patient lives see rare diseases capabilities visit all therapeutic areas see rare diseases career openings want our latest insights for rare diseases learn more ready to speak to someone on our team get in touch are you a patient interested in a clinical trial learn more the perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation promotion or advertisement for any services of parexel or any drugs or therapies including those under development participating in clinical trials for investigational medicines offers patients potential benefits such as access to cutting edge treatments and expert medical care while contributing to medical research however risks may include side effects unpredictable outcomes and time commitment careful assessment of these factors helps patients make informed decisions the content of this material including graphics images and text is provided for informational purposes only and does not constitute medical advice diagnosis or treatment please consult your healthcare professional for medical advice the patient advocate has provided their consent for the use and distribution of this content close we focus on patients because they inspire us to deliver better trials faster than ever so we can make a difference for more patients like austin disclaimer who we are parexel is proudly among the world s largest clinical research organizations a dedicated cro providing the full range of phase i to iv clinical development services and leveraging the breadth of our clinical regulatory and therapeutic expertise our team of more than 21 000 global professionals works in partnership with biopharmaceutical leaders and sites to design and deliver clinical trials with patients in mind to make clinical research a care option for anyone anywhere contact us meet us at an event resources my communication preferences invoicing po terms and conditions regional websites japan china quick links participate sites careers newsroom academy 2520 meridian parkway durham nc 27713 1 919 544 3170 privacy policy terms of service modern slavery statement act 2023 parexel international ma corporation all rights reserved
|